Overview

Clinical risk prediction estimates the likelihood and timing of outcomes such as deterioration, complications, readmission, or disease onset to support screening and care decisions. Methods range from logistic and Cox regression and clinical scores to gradient-boosted trees, survival models, temporal neural networks, and multimodal systems combining EHR data, notes, images, and wearable signals. Current work also explores calibration, uncertainty estimates, explainability, and privacy-preserving learning across hospitals. A central challenge is ensuring that strong results reflect genuine future risk and remain reliable across populations and settings, rather than being inflated by data leakage or weakened by distribution shift.

Latest papers

218 papers21 papers in the last four weeks, down 5% on the four weeks before. 0.1% of all new papers.

Mar 31, 2026

Multimodal Machine Learning for Early Prediction of Metastasis in a Swedish Multi-Cancer Cohort

Multimodal Machine Learning offers a holistic view of a patient's status, integrating structured and unstructured data from electronic health records (EHR). We propose a framework to predict metastasis risk one month prior to diagnosis, using six months of clinical history from EHR data. Data from four cancer cohorts collected at Karolinska University Hospital (Stockholm, Sweden) were analyzed: breast (n = 743), colon (n = 387), lung (n = 870), and prostate (n = 1890). The dataset included demographics, comorbidities, laboratory results, medications, and clinical text. We compared traditional and deep learning classifiers across single modalities and multimodal combinations, using various fusion strategies and a Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD) 2a design, with an 80-20 development-validation split to ensure a rigorous, repeatable evaluation. Performance was evaluated using AUROC, AUPRC, F1 score, sensitivity, and specificity. We then employed a multimodal adaptation of SHAP to analyze the classifiers' reasoning. Intermediate fusion achieved the highest F1 scores on breast (0.845), colon (0.786), and prostate cancer (0.845), demonstrating strong predictive performance. For lung cancer, the intermediate fusion achieved an F1 score of 0.819, while the text-only model achieved the highest, with an F1 score of 0.829. Deep learning classifiers consistently outperformed traditional models. Colon cancer, the smallest cohort, had the lowest performance, highlighting the importance of sufficient training data. SHAP analysis showed that the relative importance of modalities varied across cancer types. Fusion strategies offer distinct strengths and weaknesses. Intermediate fusion consistently delivered the best results, but strategy choices should align with data characteristics and organizational needs.
Mar 30, 2026

A Latent Risk-Aware Machine Learning Approach for Predicting Operational Success in Clinical Trials based on TrialsBank

Clinical trials are characterized by high costs, extended timelines, and substantial operational risk, yet reliable prospective methods for predicting trial success before initiation remain limited. Existing artificial intelligence approaches often focus on isolated metrics or specific development stages and frequently rely on variables unavailable at the trial design phase, limiting real-world applicability. We present a hierarchical latent risk-aware machine learning framework for prospective prediction of clinical trial operational success using a curated subset of TrialsBank, a proprietary AI-ready database developed by Sorintellis, comprising 13,700 trials. Operational success was defined as the ability to initiate, conduct, and complete a clinical trial according to planned timelines, recruitment targets, and protocol specifications through database lock. This approach decomposes operational success prediction into two modeling stages. First, intermediate latent operational risk factors are predicted using more than 180 drug- and trial-level features available before trial initiation. These predicted latent risks are then integrated into a downstream model to estimate the probability of operational success. A staged data-splitting strategy was employed to prevent information leakage, and models were benchmarked using XGBoost, CatBoost, and Explainable Boosting Machines. Across Phase I-III, the framework achieves strong out-of-sample performance, with F1-scores of 0.93, 0.92, and 0.91, respectively. Incorporating latent risk drivers improves discrimination of operational failures, and performance remains robust under independent inference evaluation. These results demonstrate that clinical trial operational success can be prospectively forecasted using a latent risk-aware AI framework, enabling early risk assessment and supporting data-driven clinical development decision-making.
Mar 27, 2026

Improving Risk Stratification in Hypertrophic Cardiomyopathy: A Novel Score Combining Echocardiography, Clinical, and Medication Data

Hypertrophic cardiomyopathy (HCM) requires accurate risk stratification to inform decisions regarding ICD therapy and follow-up management. Current established models, such as the European Society of Cardiology (ESC) score, exhibit moderate discriminative performance. This study develops a robust, explainable machine learning (ML) risk score leveraging routinely collected echocardiographic, clinical, and medication data, typically contained within Electronic Health Records (EHRs), to predict a 5-year composite cardiovascular outcome in HCM patients. The model was trained and internally validated using a large cohort (N=1,201) from the SHARE registry (Florence Hospital) and externally validated on an independent cohort (N=382) from Rennes Hospital. The final Random Forest ensemble model achieved a high internal Area Under the Curve (AUC) of 0.85 +- 0.02, significantly outperforming the ESC score (0.56 +- 0.03). Critically, survival curve analysis on the external validation set showed superior risk separation for the ML score (Log-rank p = 8.62 x 10^(-4) compared to the ESC score (p = 0.0559). Furthermore, longitudinal analyses demonstrate that the proposed risk score remains stable over time in event-free patients. The model high interpretability and its capacity for longitudinal risk monitoring represent promising tools for the personalized clinical management of HCM.
Mar 25, 2026

CORA: Generalizable coronary artery disease assessment and risk stratification from coronary CT angiography using pathology-centric representation learning

Coronary artery disease, a leading cause of cardiovascular mortality worldwide, can be assessed non-invasively by coronary computed tomography angiography (CCTA). Although deep learning has advanced automated CCTA analysis, clinical translation remains constrained by the scarcity of expert-annotated data and by the spatial sparsity of coronary pathology, which occupies only a small fraction of each scan. Widely used label-free pretraining strategies, such as masked image modeling and contrastive learning, optimize for global anatomical reconstruction and tend to under-represent these tiny localized pathological features. Here we present CORA, an annotation-efficient model for comprehensive coronary artery disease assessment. Rather than reconstructing background anatomy, CORA learns from volumetric CCTA through a synthesis-driven self-supervised strategy: an anatomy-guided engine inserts diverse synthetic calcified and non-calcified lesions into unlabeled scans, reframing pretraining as an abnormality-detection task that biases representation learning toward clinically relevant disease features. We pretrained CORA on 10,138 unlabeled CCTA volumes and evaluated it across datasets from nine independent hospitals. Across plaque characterization, stenosis detection, and coronary artery segmentation, CORA consistently outperformed strong self-supervised pretraining baselines, with the largest gains on external multi-center data, indicating robust generalization under distributional shift. Coupling the imaging encoder with structured clinical variables further enabled near-term major adverse cardiac event (MACE) risk stratification. Our results show that pathology-centric, synthesis-driven pretraining is an effective and scalable strategy for annotation-efficient coronary artery disease assessment from CCTA.
Mar 23, 2026

PPGL-Swarm: Integrated Multimodal Risk Stratification and Hereditary Syndrome Detection in Pheochromocytoma and Paraganglioma

Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors, of which 15-25% develop metastatic disease with 5-year survival rates reported as low as 34%. PPGL may indicate hereditary syndromes requiring stricter, syndrome-specific treatment and surveillance, but clinicians often fail to recognize these associations in routine care. Clinical practice uses GAPP score for PPGL grading, but several limitations remain for PPGL diagnosis: (1) GAPP scoring demands a high workload for clinician because it requires the manual evaluation of six independent components; (2) key components such as cellularity and Ki-67 are often evaluated with subjective criteria; (3) several clinically relevant metastatic risk factors are not captured by GAPP, such as SDHB mutations, which have been associated with reported metastatic rates of 35-75%. Agent-driven diagnostic systems appear promising, but most lack traceable reasoning for decision-making and do not incorporate domain-specific knowledge such as PPGL genotype information. To address these limitations, we present PPGL-Swarm, an agentic PPGL diagnostic system that generates a comprehensive report, including automated GAPP scoring (with quantified cellularity and Ki-67), genotype risk alerts, and multimodal report with integrated evidence. The system provides an auditable reasoning trail by decomposing diagnosis into micro-tasks, each assigned to a specialized agent. The gene and table agents use knowledge enhancement to better interpret genotype and laboratory findings, and during training we use reinforcement learning to refine tool selection and task assignment.
Mar 23, 2026

Cerebra: A Multidisciplinary AI Board for Multimodal Dementia Characterization and Risk Assessment

Modern clinical practice increasingly depends on reasoning over heterogeneous, evolving, and incomplete patient data. Although recent advances in multimodal foundation models have improved performance on various clinical tasks, most existing models remain static, opaque, and poorly aligned with real-world clinical workflows. We present Cerebra, an interactive multi-agent AI team that coordinates specialized agents for EHR, clinical notes, and medical imaging analysis. These outputs are synthesized into a clinician-facing dashboard that combines visual analytics with a conversational interface, enabling clinicians to interrogate predictions and contextualize risk at the point of care. Cerebra supports privacy-preserving deployment by operating on structured representations and remains robust when modalities are incomplete. We evaluated Cerebra using a massive multi-institutional dataset spanning 3 million patients from four independent healthcare systems. Cerebra consistently outperformed both state-of-the-art single-modality models and large multimodal language model baselines. In dementia risk prediction, it achieved AUROCs up to 0.80, compared with 0.74 for the strongest single-modality model and 0.68 for language model baselines. For dementia diagnosis, it achieved an AUROC of 0.86, and for survival prediction, a C-index of 0.81. In a reader study with experienced physicians, Cerebra significantly improved expert performance, increasing accuracy by 17.5 percentage points in prospective dementia risk estimation. These results demonstrate Cerebra's potential for interpretable, robust decision support in clinical care.
Mar 22, 2026

Representation-Level Adversarial Regularization for Clinically Aligned Multitask Thyroid Ultrasound Assessment

Thyroid ultrasound is the first-line exam for assessing thyroid nodules and determining whether biopsy is warranted. In routine reporting, radiologists produce two coupled outputs: a nodule contour for measurement and a TI-RADS risk category based on sonographic criteria. Yet both contouring style and risk grading vary across readers, creating inconsistent supervision that can degrade standard learning pipelines. In this paper, we address this workflow with a clinically guided multitask framework that jointly predicts the nodule mask and TI-RADS category within a single model. To ground risk prediction in clinically meaningful evidence, we guide the classification embedding using a compact TI-RADS aligned radiomics target during training, while preserving complementary deep features for discriminative performance. However, under annotator variability, naive multitask optimization often fails not because the tasks are unrelated, but because their gradients compete within the shared representation. To make this competition explicit and controllable, we introduce RLAR, a representation-level adversarial gradient regularizer. Rather than performing parameter-level gradient surgery, RLAR uses each task's normalized adversarial direction in latent space as a geometric probe of task sensitivity and penalizes excessive angular alignment between task-specific adversarial directions. On a public TI-RADS dataset, our clinically guided multitask model with RLAR consistently improves risk stratification while maintaining segmentation quality compared to single-task training and conventional multitask baselines. Code and pretrained models will be released.
Mar 17, 2026

Federated Learning with Multi-Partner OneFlorida+ Consortium Data for Predicting Major Postoperative Complications

Background: This study aims to develop and validate federated learning models for predicting major postoperative complications and mortality using a large multicenter dataset from the OneFlorida Data Trust. We hypothesize that federated learning models will offer robust generalizability while preserving data privacy and security. Methods: This retrospective, longitudinal, multicenter cohort study included 358,644 adult patients admitted to five healthcare institutions, who underwent 494,163 inpatient major surgical procedures from 2012-2023. We developed and internally and externally validated federated learning models to predict the postoperative risk of intensive care unit (ICU) admission, mechanical ventilation (MV) therapy, acute kidney injury (AKI), and in-hospital mortality. These models were compared with local models trained on data from a single center and central models trained on a pooled dataset from all centers. Performance was primarily evaluated using area under the receiver operating characteristics curve (AUROC) and the area under the precision-recall curve (AUPRC) values. Results: Our federated learning models demonstrated strong predictive performance, with AUROC scores consistently comparable or superior performance in terms of AUROC and AUPRC across all outcomes and sites. Our federated learning models also demonstrated strong generalizability, with comparable or superior performance in terms of both AUROC and AUPRC compared to the best local learning model at each site. Conclusions: By leveraging multicenter data, we developed robust, generalizable, and privacy-preserving predictive models for major postoperative complications and mortality. These findings support the feasibility of federated learning in clinical decision support systems.
Mar 16, 2026

CrossADR: enhancing adverse drug reactions prediction for combination pharmacotherapy with cross-layer feature integration and cross-level associative learning

Combination pharmacotherapy offers substantial therapeutic advantages but also poses substantial risks of adverse drug reactions (ADRs). The accurate prediction of ADRs with interpretable computational methods is crucial for clinical safety management, drug development, and precision medicine. However, managing ADRs remains a challenge due to the vast search space of drug combinations and the complexity of physiological responses. Current graph-based architectures often struggle to effectively integrate multi-scale biological information and frequently rely on fixed association matrices, which limits their ability to capture dynamic organ-level dependencies and generalize across diverse datasets. Here we propose CrossADR, a hierarchical framework for organ-level ADR prediction through cross-layer feature integration and cross-level associative learning. It incorporates a gated-residual-flow graph neural network to fuse multi-scale molecular features and utilizes a learnable ADR embedding space to dynamically capture latent biological correlations across 15 organ systems. Systematic evaluation on the newly constructed CrossADR-Dataset-covering 1,376 drugs and 946,000 unique combinations-demonstrates that CrossADR consistently achieves state-of-the-art performance across 80 distinct experimental scenarios and provides high-resolution insights into drug-related protein protein interactions and pathways. Overall, CrossADR represents a robust tool for cross-scale biomedical information integration, cross-layer feature integration as well as cross-level associative learning, and can be effectively utilized to prevent ADRs in clinical decision-making.
Mar 16, 2026

Multimodal Deep Learning for Early Prediction of Patient Deterioration in the ICU: Integrating Time-Series EHR Data with Clinical Notes

Early identification of patients at risk for clinical deterioration in the intensive care unit (ICU) remains a critical challenge. Delayed recognition of impending adverse events, including mortality, vasopressor initiation, and mechanical ventilation, contributes to preventable morbidity and mortality. We present a multimodal deep learning approach that combines structured time-series data (vital signs and laboratory values) with unstructured clinical notes to predict patient deterioration within 24 hours. Using the MIMIC-IV database, we constructed a cohort of 74,822 ICU stays and generated 5.7 million hourly prediction samples. Our architecture employs a bidirectional LSTM encoder for temporal patterns in physiologic data and ClinicalBERT embeddings for clinical notes, fused through a cross-modal attention mechanism. We also present a systematic review of existing approaches to ICU deterioration prediction, identifying 31 studies published between 2015 and 2024. Most existing models rely solely on structured data and achieve area under the curve (AUC) values between 0.70 and 0.85. Studies incorporating clinical notes remain rare but show promise for capturing information not present in structured fields. Our multimodal model achieves a test AUROC of 0.7857 and AUPRC of 0.1908 on 823,641 held-out samples, with a validation-to-test gap of only 0.6 percentage points. Ablation analysis validates the multimodal approach: clinical notes improve AUROC by 2.5 percentage points and AUPRC by 39.2% relative to a structured-only baseline, while deep learning models consistently outperform classical baselines (XGBoost AUROC: 0.7486, logistic regression: 0.7171). This work contributes both a thorough review of the field and a reproducible multimodal framework for clinical deterioration prediction.
Mar 15, 2026

Deep Learning From Routine Histology Improves Risk Stratification for Biochemical Recurrence in Prostate Cancer

Accurate prediction of biochemical recurrence (BCR) after radical prostatectomy is critical for guiding adjuvant treatment and surveillance decisions in prostate cancer. However, existing clinicopathological risk models reduce complex morphology to relatively coarse descriptors, leaving substantial prognostic information embedded in routine histopathology underexplored. We present a deep learning-based biomarker that predicts continuous, patient-specific risk of BCR directly from H&E-stained whole-slide prostatectomy specimens. Trained end-to-end on time-to-event outcomes and evaluated across four independent international cohorts, our model demonstrates robust generalization across institutions and patient populations. When integrated with the CAPRA-S clinical risk score, the deep learning risk score consistently improved discrimination for BCR, increasing concordance indices from 0.725-0.772 to 0.749-0.788 across cohorts. To support clinical interpretability, outcome-grounded analyses revealed subtle histomorphological patterns associated with recurrence risk that are not captured by conventional clinicopathological risk scores. This multicohort study demonstrates that deep learning applied to routine prostate histopathology can deliver reproducible and clinically generalizable biomarkers that augment postoperative risk stratification, with potential to support personalized management of prostate cancer in real-world clinical settings.
Mar 12, 2026

Bridging the Visual-to-Physical Gap: Physically Aligned Representations for Fall Risk Analysis

Vision-based fall analysis has advanced rapidly, but a key bottleneck remains: visually similarmotions can correspond to very different physical outcomes because small differences in contactmechanics and protective responses are hard to infer from appearance alone. Most existingapproaches handle this by supervised injury prediction, which depends on reliable injury labels.In practice, such labels are difficult to obtain: video evidence is often ambiguous (occlusion,viewpoint limits), and true injury events are rare and cannot be safely staged, leading to noisysupervision. We address this problem with PHARL (PHysics-aware Alignment RepresentationLearning), which learns physically meaningful fall representations without requiring clinicaloutcome labels. PHARL regularizes motion embeddings with two complementary constraints:(1) trajectory-level temporal consistency for stable representation learning, and (2) multi-classphysics alignment, where simulation-derived contact outcomes shape embedding geometry. Bypairing video windows with temporally aligned simulation descriptors, PHARL captures localimpact-relevant dynamics while keeping inference purely feed-forward. Experiments on fourpublic datasets show that PHARL consistently improves risk-aligned representation quality overvisual-only baselines while maintaining strong fall-detection performance. Notably, PHARL alsoexhibits zero-shot ordinality: an interpretable severity structure (Head > Trunk > Supported)emerges without explicit ordinal supervision.
Mar 12, 2026

Survival Meets Classification: A Novel Framework for Early Risk Prediction Models of Chronic Diseases

Chronic diseases are long-lasting conditions that require lifelong medical attention. Using big EMR data, we have developed early disease risk prediction models for five common chronic diseases: diabetes, hypertension, CKD, COPD, and chronic ischemic heart disease. In this study, we present a novel approach for disease risk models by integrating survival analysis with classification techniques. Traditional models for predicting the risk of chronic diseases predominantly focus on either survival analysis or classification independently. In this paper, we show survival analysis methods can be re-engineered to enable them to do classification efficiently and effectively, thereby making them a comprehensive tool for developing disease risk surveillance models. The results of our experiments on real-world big EMR data show that the performance of survival models in terms of accuracy, F1 score, and AUROC is comparable to or better than that of prior state-of-the-art models like LightGBM and XGBoost. Lastly, the proposed survival models use a novel methodology to generate explanations, which have been clinically validated by a panel of three expert physicians.
Mar 11, 2026

PRIME-CVD: A Parametrically Rendered Informatics Medical Environment for Education in Cardiovascular Risk Modelling

In recent years, progress in medical informatics and machine learning has been accelerated by the availability of openly accessible benchmark datasets. However, patient-level electronic medical record (EMR) data are rarely available for teaching or methodological development due to privacy, governance, and re-identification risks. This has limited reproducibility, transparency, and hands-on training in cardiovascular risk modelling. Here we introduce PRIME-CVD, a parametrically rendered informatics medical environment designed explicitly for medical education. PRIME-CVD comprises two openly accessible synthetic data assets representing a cohort of 50,000 adults undergoing primary prevention for cardiovascular disease. The datasets are generated entirely from a user-specified causal directed acyclic graph parameterised using publicly available Australian population statistics and published epidemiologic effect estimates, rather than from patient-level EMR data or trained generative models. Data Asset 1 provides a clean, analysis-ready cohort suitable for exploratory analysis, stratification, and survival modelling, while Data Asset 2 restructures the same cohort into a relational, EMR-style database with realistic structural and lexical heterogeneity. Together, these assets enable instruction in data cleaning, harmonisation, causal reasoning, and policy-relevant risk modelling without exposing sensitive information. Because all individuals and events are generated de novo, PRIME-CVD preserves realistic subgroup imbalance and risk gradients while ensuring negligible disclosure risk. PRIME-CVD is released under a Creative Commons Attribution 4.0 licence to support reproducible research and scalable medical education.
Mar 10, 2026

Automatic Cardiac Risk Management Classification using large-context Electronic Patients Health Records

To overcome the limitations of manual administrative coding in geriatric Cardiovascular Risk Management, this study introduces an automated classification framework leveraging unstructured Electronic Health Records (EHRs). Using a dataset of 3,482 patients, we benchmarked three distinct modeling paradigms on longitudinal Dutch clinical narratives: classical machine learning baselines, specialized deep learning architectures optimized for large-context sequences, and general-purpose generative Large Language Models (LLMs) in a zero-shot setting. Additionally, we evaluated a late fusion strategy to integrate unstructured text with structured medication embeddings and anthropometric data. Our analysis reveals that the custom Transformer architecture outperforms both traditional methods and generative \acs{llm}s, achieving the highest F1-scores and Matthews Correlation Coefficients. These findings underscore the critical role of specialized hierarchical attention mechanisms in capturing long-range dependencies within medical texts, presenting a robust, automated alternative to manual workflows for clinical risk stratification.
Mar 9, 2026

Data-Driven Priors for Uncertainty-Aware Risk Prediction of Clinical Deterioration using Multimodal Data

Safe predictions are a crucial requirement for integrating predictive models into clinical decision support systems. One approach to improving trustworthiness is to enable models to express uncertainty about individual predictions. However, current machine learning models frequently lack reliable uncertainty estimation, hindering real-world deployment. This limitation is particularly evident in multimodal settings, where models must effectively integrate heterogeneous information. In this work, we propose MedCertAIn, a predictive uncertainty framework that leverages multimodal clinical data to improve model performance and reliability for in-hospital mortality risk prediction as an indicator of patient deterioration. We design data-driven priors over neural network parameters using a hybrid strategy that considers cross-modal similarity in self-supervised latent representations and modality-specific data corruptions. We train and evaluate the models with such priors using clinical time-series and chest X-ray images from the publicly available datasets MIMIC-IV and MIMIC-CXR. Our results show that MedCertAIn achieves competitive predictive performance and substantial gains in selective prediction compared with the evaluated deterministic and stochastic baselines. These findings highlight the promise of data-driven priors in advancing robust, uncertainty-aware AI tools for high-stakes clinical applications. Our implementation is publicly available at: https://github.com/jlaitue/medcertain.
Mar 7, 2026

Learning Clinical Representations Under Systematic Distribution Shift

Clinical machine learning models are increasingly trained using large scale, multimodal foundation paradigms, yet deployment environments often differ systematically from the data generating settings used during training. Such shifts arise from heterogeneous measurement policies, documentation practices, and institutional workflows, leading to representation entanglement between physiologic signal and practice specific artifacts. In this work, we propose a practice invariant representation learning framework for multimodal clinical prediction. We model clinical observations as arising from latent physiologic factors and environment dependent processes, and introduce an objective that jointly optimizes predictive performance while suppressing environment predictive information in the learned embedding. Concretely, we combine supervised risk minimization with adversarial environment regularization and invariant risk penalties across hospitals. Across multiple longitudinal EHR prediction tasks and cross institution evaluations, our method improves out of distribution AUROC by up to 2 to 3 points relative to masked pretraining and standard supervised baselines, while maintaining in distribution performance and improving calibration. These results demonstrate that explicitly accounting for systematic distribution shift during representation learning yields more robust and transferable clinical models, highlighting the importance of structural invariance alongside architectural scale in healthcare AI.
Mar 5, 2026

Early Warning of Intraoperative Adverse Events via Transformer-Driven Multi-Label Learning

Early warning of intraoperative adverse events plays a vital role in reducing surgical risk and improving patient safety. While deep learning has shown promise in predicting the single adverse event, several key challenges remain: overlooking adverse event dependencies, underutilizing heterogeneous clinical data, and suffering from the class imbalance inherent in medical datasets. To address these issues, we construct the first Multi-label Adverse Events dataset (MuAE) for intraoperative adverse events prediction, covering six critical events. Next, we propose a novel Transformerbased multi-label learning framework (IAENet) that combines an improved Time-Aware Feature-wise Linear Modulation (TAFiLM) module for static covariates and dynamic variables robust fusion and complex temporal dependencies modeling. Furthermore, we introduce a Label-Constrained Reweighting Loss (LCRLoss) with co-occurrence regularization to effectively mitigate intra-event imbalance and enforce structured consistency among frequently co-occurring events. Extensive experiments demonstrate that IAENet consistently outperforms strong baselines on 5, 10, and 15-minute early warning tasks, achieving improvements of +5.05%, +2.82%, and +7.57% on average F1 score. These results highlight the potential of IAENet for supporting intelligent intraoperative decision-making in clinical practice.
Mar 2, 2026

Enhanced Atrial Fibrillation Prediction in ESUS Patients with Hypergraph-based Pre-training

Atrial fibrillation (AF) is a major complication following embolic stroke of undetermined source (ESUS), elevating the risk of recurrent stroke and mortality. Early identification is clinically important, yet existing tools face limitations in accuracy, scalability, and cost. Machine learning (ML) offers promise but is hindered by small ESUS cohorts and high-dimensional medical features. To address these challenges, we introduce supervised and unsupervised hypergraph-based pre-training strategies to improve AF prediction in ESUS patients. We first pre-train hypergraph-based patient embedding models on a large stroke cohort (7,780 patients) to capture salient features and higher-order interactions. The resulting embeddings are transferred to a smaller ESUS cohort (510 patients), reducing feature dimensionality while preserving clinically meaningful information, enabling effective prediction with lightweight models. Experiments show that both pre-training approaches outperform traditional models trained on raw data, improving accuracy and robustness. This framework offers a scalable and efficient solution for AF risk prediction after stroke.
Feb 28, 2026

A Robust Framework for Secure Cardiovascular Risk Prediction: An Architectural Case Study of Differentially Private Federated Learning

Accurate cardiovascular risk prediction is crucial for preventive healthcare; however, the development of robust Artificial Intelligence (AI) models is hindered by the fragmentation of clinical data across institutions due to stringent privacy regulations. This paper presents a comprehensive architectural case study validating the engineering robustness of FedCVR, a privacy-preserving Federated Learning framework applied to heterogeneous clinical networks. Rather than proposing a new theoretical optimizer, this work focuses on a systems engineering analysis to quantify the operational trade-offs of server-side adaptive optimization under utility-prioritized Differential Privacy (DP). By conducting a rigorous stress test in a high-fidelity synthetic environment that reflects the feature space and clinical context of real-world datasets (Framingham, Cleveland), we systematically evaluate the system's resilience to statistical noise. The validation results demonstrate that integrating server-side momentum as a temporal denoiser enables the architecture to achieve a stable F1 score of 0.78 and an Area Under the Curve (AUC) of 0.96 under the operational privacy budget (epsilon approximately 13.4), compared to a non-private baseline with an F1 score of 0.84. FedCVR statistically outperforms standard stateless baselines (FedAvg, FedProx) and other adaptive optimizers (FedAdagrad, FedYogi) under identical privacy constraints. Our findings confirm that server-side adaptivity is a structural prerequisite for recovering clinical utility under realistic privacy budgets, providing a validated engineering blueprint for secure multi-institutional collaboration.
Feb 27, 2026

Tipping the Balance: Impact of Class Imbalance Correction on the Performance of Clinical Risk Prediction Models

Objective: ML-based clinical risk prediction models are increasingly used to support decision-making in healthcare. While class-imbalance correction techniques are commonly applied to improve model performance in settings with rare outcomes, their impact on probabilistic calibration remains insufficiently understood. This study evaluated the effect of widely used resampling strategies on both discrimination and calibration across real-world clinical prediction tasks. Methods: Ten clinical datasets spanning diverse medical domains and including 605,842 patients were analyzed. Multiple machine-learning model families, including linear models and several non-linear approaches, were evaluated. Models were trained on the original data and under three commonly used 1:1 class-imbalance correction strategies (SMOTE, RUS, ROS). Performance was assessed on held-out data using discrimination and calibration metrics. Results: Across all datasets and model families, resampling had no positive impact on predictive performance. Changes in the Receiver Operating Characteristic Area Under Curve (ROC-AUC) relative to models trained on the original data were small and inconsistent (ROS: -0.002, p<0.05; RUS: -0.004, p>0.05; SMOTE: -0.01, p<0.05), with no resampling strategy demonstrating a systematic improvement. In contrast, resampling in general degraded the calibration performance. Models trained using imbalance correction exhibited higher Brier scores (0.029 to 0.080, p<0.05), reflecting poorer probabilistic accuracy, and marked deviations in calibration intercept and slope, indicating systematic distortions of predicted risk despite preserved rank-based performance. Conclusion: In a diverse set of real-world clinical prediction tasks, commonly used class-imbalance correction techniques did not provide generalizable improvements in discrimination and were associated with degraded calibration.
Feb 27, 2026

Diagnostics for Individual-Level Prediction Instability in Machine Learning for Healthcare

In healthcare, predictive models increasingly inform patient-level decisions, yet little attention is paid to the variability in individual risk estimates and its impact on treatment decisions. For overparameterized models, now standard in machine learning, a substantial source of variability often goes undetected. Even when the data and model architecture are held fixed, randomness introduced by optimization and initialization can lead to materially different risk estimates for the same patient. This problem is largely obscured by standard evaluation practices, which rely on aggregate performance metrics (e.g., log-loss, accuracy) that are agnostic to individual-level stability. As a result, models with indistinguishable aggregate performance can nonetheless exhibit substantial procedural arbitrariness, which can undermine clinical trust. We propose an evaluation framework that quantifies individual-level prediction instability by using two complementary diagnostics: empirical prediction interval width (ePIW), which captures variability in continuous risk estimates, and empirical decision flip rate (eDFR), which measures instability in threshold-based clinical decisions. We apply these diagnostics to simulated data and GUSTO-I clinical dataset. Across observed settings, we find that for flexible machine-learning models, randomness arising solely from optimization and initialization can induce individual-level variability comparable to that produced by resampling the entire training dataset. Neural networks exhibit substantially greater instability in individual risk predictions compared to logistic regression models. Risk estimate instability near clinically relevant decision thresholds can alter treatment recommendations. These findings that stability diagnostics should be incorporated into routine model validation for assessing clinical reliability.
Feb 26, 2026

A Data-Driven Approach to Support Clinical Renal Replacement Therapy

This study investigates a data-driven machine learning approach to predict membrane fouling in critically ill patients undergoing Continuous Renal Replacement Therapy (CRRT). Using time-series data from an ICU, 16 clinically selected features were identified to train predictive models. To ensure interpretability and enable reliable counterfactual analysis, the researchers adopted a tabular data approach rather than modeling temporal dependencies directly. Given the imbalance between fouling and non-fouling cases, the ADASYN oversampling technique was applied to improve minority class representation. Random Forest, XGBoost, and LightGBM models were tested, achieving balanced performance with 77.6% sensitivity and 96.3% specificity at a 10% rebalancing rate. Results remained robust across different forecasting horizons. Notably, the tabular approach outperformed LSTM recurrent neural networks, suggesting that explicit temporal modeling was not necessary for strong predictive performance. Feature selection further reduced the model to five key variables, improving simplicity and interpretability with minimal loss of accuracy. A Shapley value-based counterfactual analysis was applied to the best-performing model, successfully identifying minimal input changes capable of reversing fouling predictions. Overall, the findings support the viability of interpretable machine learning models for predicting membrane fouling during CRRT. The integration of prediction and counterfactual analysis offers practical clinical value, potentially guiding therapeutic adjustments to reduce fouling risk and improve patient management.
Feb 25, 2026

Enhancing Framingham Cardiovascular Risk Score Transparency through Logic-Based XAI

Cardiovascular disease (CVD) remains one of the leading global health challenges, accounting for more than 19 million deaths worldwide. To address this, several tools that aim to predict CVD risk and support clinical decision making have been developed. In particular, the Framingham Risk Score (FRS) is one of the most widely used and recommended worldwide. However, it does not explain why a patient was assigned to a particular risk category nor how it can be reduced. Due to this lack of transparency, we present a logical explainer for the FRS. Based on first-order logic and explainable artificial intelligence (XAI) fundaments, the explainer is capable of identifying a minimal set of patient attributes that are sufficient to explain a given risk classification. Our explainer also produces actionable scenarios that illustrate which modifiable variables would reduce a patient's risk category. We evaluated all possible input combinations of the FRS (over 22,000 samples) and tested them with our explainer, successfully identifying important risk factors and suggesting focused interventions for each case. The results may improve clinician trust and facilitate a wider implementation of CVD risk assessment by converting opaque scores into transparent and prescriptive insights, particularly in areas with restricted access to specialists.
Feb 25, 2026

Reliable XAI Explanations in Sudden Cardiac Death Prediction for Chagas Cardiomyopathy

Sudden cardiac death (SCD) is unpredictable, and its prediction in Chagas cardiomyopathy (CC) remains a significant challenge, especially in patients not classified as high risk. While AI and machine learning models improve risk stratification, their adoption is hindered by a lack of transparency, as they are often perceived as black boxes with unclear decision-making processes. Some approaches apply heuristic explanations without correctness guarantees, leading to mistakes in the decision-making process. To address this, we apply a logic-based explainability method with correctness guarantees to the problem of SCD prediction in CC. This explainability method, applied to an AI classifier with over 95% accuracy and recall, demonstrated strong predictive performance and 100% explanation fidelity. When compared to state-of-the-art heuristic methods, it showed superior consistency and robustness. This approach enhances clinical trust, facilitates the integration of AI-driven tools into practice, and promotes large-scale deployment, particularly in endemic regions where it is most needed.
Feb 25, 2026

Early Risk Stratification of Dosing Errors in Clinical Trials Using Machine Learning

Objective: The objective of this study is to develop a machine learning (ML)-based framework for early risk stratification of clinical trials (CTs) according to their likelihood of exhibiting a high rate of dosing errors, using information available prior to trial initiation. Materials and Methods: We constructed a dataset from ClinicalTrials.gov comprising 42,112 CTs. Structured, semi-structured trial data, and unstructured protocol-related free-text data were extracted. CTs were assigned binary labels indicating elevated dosing error rate, derived from adverse event reports, MedDRA terminology, and Wilson confidence intervals. We evaluated an XGBoost model trained on structured features, a ClinicalModernBERT model using textual data, and a simple late-fusion model combining both modalities. Post-hoc probability calibration was applied to enable interpretable, trial-level risk stratification. Results: The late-fusion model achieved the highest AUC-ROC (0.862). Beyond discrimination, calibrated outputs enabled robust stratification of CTs into predefined risk categories. The proportion of trials labeled as having an excessively high dosing error rate increased monotonically across higher predicted risk groups and aligned with the corresponding predicted probability ranges. Discussion: These findings indicate that dosing error risk can be anticipated at the trial level using pre-initiation information. Probability calibration was essential for translating model outputs into reliable and interpretable risk categories, while simple multimodal integration yielded performance gains without requiring complex architectures. Conclusion: This study introduces a reproducible and scalable ML framework for early, trial-level risk stratification of CTs at risk of high dosing error rates, supporting proactive, risk-based quality management in clinical research.
Feb 25, 2026

Integrating Machine Learning Ensembles and Large Language Models for Heart Disease Prediction Using Voting Fusion

Cardiovascular disease is the primary cause of death globally, necessitating early identification, precise risk classification, and dependable decision-support technologies. The advent of large language models (LLMs) provides new zero-shot and few-shot reasoning capabilities, even though machine learning (ML) algorithms, especially ensemble approaches like Random Forest, XGBoost, LightGBM, and CatBoost, are excellent at modeling complex, non-linear patient data and routinely beat logistic regression. This research predicts cardiovascular disease using a merged dataset of 1,190 patient records, comparing traditional machine learning models (95.78% accuracy, ROC-AUC 0.96) with open-source large language models via OpenRouter APIs. Finally, a hybrid fusion of the ML ensemble and LLM reasoning under Gemini 2.5 Flash achieved the best results (96.62% accuracy, 0.97 AUC), showing that LLMs (78.9 % accuracy) work best when combined with ML models rather than used alone. Results show that ML ensembles achieved the highest performance (95.78% accuracy, ROC-AUC 0.96), while LLMs performed moderately in zero-shot (78.9%) and slightly better in few-shot (72.6%) settings. The proposed hybrid method enhanced the strength in uncertain situations, illustrating that ensemble ML is considered the best structured tabular prediction case, but it can be integrated with hybrid ML-LLM systems to provide a minor increase and open the way to more reliable clinical decision-support tools.
Feb 20, 2026

Improving Generalizability of Hip Fracture Risk Prediction via Domain Adaptation Across Multiple Cohorts

Clinical risk prediction models often fail to be generalized across cohorts because underlying data distributions differ by clinical site, region, demographics, and measurement protocols. This limitation is particularly pronounced in hip fracture risk prediction, where the performance of models trained on one cohort (the source cohort) can degrade substantially when deployed in other cohorts (target cohorts). We used a shared set of clinical and DXA-derived features across three large cohorts - the Study of Osteoporotic Fractures (SOF), the Osteoporotic Fractures in Men Study (MrOS), and the UK Biobank (UKB), to systematically evaluate the performance of three domain adaptation methods - Maximum Mean Discrepancy (MMD), Correlation Alignment (CORAL), and Domain - Adversarial Neural Networks (DANN) and their combinations. For a source cohort with males only and a source cohort with females only, domain-adaptation methods consistently showed improved performance than the no-adaptation baseline (source-only training), and the use of combinations of multiple domain adaptation methods delivered the largest and most stable gains. The method that combines MMD, CORAL, and DANN achieved the highest discrimination with the area under curve (AUC) of 0.88 for a source cohort with males only and 0.95 for a source cohort with females only), demonstrating that integrating multiple domain adaptation methods could produce feature representations that are less sensitive to dataset differences. Unlike existing methods that rely heavily on supervised tuning or assume known outcomes of samples in target cohorts, our outcome-free approaches enable the model selection under realistic deployment conditions and improve generalization of models in hip fracture risk prediction.
Feb 19, 2026

The Sound of Death: Deep Learning Reveals Vascular Damage from Carotid Ultrasound

Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, yet early risk detection is often limited by available diagnostics. Carotid ultrasound, a non-invasive and widely accessible modality, encodes rich structural and hemodynamic information that is largely untapped. Here, we present a machine learning (ML) framework that extracts clinically meaningful representations of vascular damage (VD) from carotid ultrasound videos, using hypertension as a weak proxy label. The model learns robust features that are biologically plausible, interpretable, and strongly associated with established cardiovascular risk factors, comorbidities, and laboratory measures. High VD stratifies individuals for myocardial infarction, cardiac death, and all-cause mortality, matching or outperforming conventional risk models such as SCORE2. Explainable AI analyses reveal that the model relies on vessel morphology and perivascular tissue characteristics, uncovering novel functional and anatomical signatures of vascular damage. This work demonstrates that routine carotid ultrasound contains far more prognostic information than previously recognized. Our approach provides a scalable, non-invasive, and cost-effective tool for population-wide cardiovascular risk assessment, enabling earlier and more personalized prevention strategies without reliance on laboratory tests or complex clinical inputs.
Feb 18, 2026

Construction of a classification model for dementia among Brazilian adults aged 50 and over

To build a dementia classification model for middle-aged and elderly Brazilians, implemented in Python, combining variable selection and multivariable analysis, using low-cost variables with modification potential. Observational study with a predictive modeling approach using a cross-sectional design, aimed at estimating the chances of developing dementia, using data from the Brazilian Longitudinal Study of Aging (ELSI-Brazil), involving 9,412 participants. Dementia was determined based on neuropsychological assessment and informant-based cognitive function. Analyses were performed using Random Forest (RF) and multivariable logistic regression to estimate the risk of dementia in the middle-aged and elderly populations of Brazil. The prevalence of dementia was 9.6%. The highest odds of dementia were observed in illiterate individuals (Odds Ratio (OR) = 7.42), individuals aged 90 years or older (OR = 11.00), low weight (OR = 2.11), low handgrip strength (OR = 2.50), self-reported black skin color (OR = 1.47), physical inactivity (OR = 1.61), self-reported hearing loss (OR = 1.65), and presence of depressive symptoms (OR = 1.72). Higher education (OR=0.44), greater life satisfaction (OR=0.72), and being employed (OR=0.78) were protective factors. The RF model outperformed logistic regression, achieving an area under the ROC curve of 0.776, with a sensitivity of 0.708, a specificity of 0.702, an F1-score of 0.311, a G-means of 0.705, and an accuracy of 0.703. Conclusion: The findings reinforce the multidimensional nature of dementia and the importance of accessible factors for identifying vulnerable individuals. Strengthening public policies focused on promoting brain health can contribute significantly to the efficient allocation of resources in primary care and dementia prevention in Brazil